Trexquant Investment LP - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 138 filers reported holding CARA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.55 and the average weighting 0.4%.

Quarter-by-quarter ownership
Trexquant Investment LP ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$54,904
-87.9%
11,182
-70.1%
0.00%
-90.5%
Q1 2022$454,000
+135.2%
37,339
+146.6%
0.02%
+75.0%
Q3 2020$193,000
-6.3%
15,140
-3.0%
0.01%
-20.0%
Q1 2020$206,000
+167.5%
15,616
-2.1%
0.02%
+50.0%
Q2 2016$77,000
-77.7%
15,951
-71.4%
0.01%
-75.6%
Q1 2016$346,000
-52.8%
55,676
+28.0%
0.04%
-36.9%
Q4 2015$733,000
-10.5%
43,500
-24.1%
0.06%
-7.1%
Q3 2015$819,00057,3500.07%
Other shareholders
CARA THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 3,193,057$51,440,00039.10%
Chescapmanager LLC 1,299,701$20,938,0003.08%
Burrage Capital Management LLC 284,170$4,578,0003.07%
Cypress Capital Management LLC (WY) 184,085$2,966,0002.80%
DAFNA Capital Management LLC 328,533$5,293,0001.82%
Mesirow Financial Investment Management, Inc. 21,169$341,0001.44%
KINGDON CAPITAL MANAGEMENT, L.L.C. 471,575$7,597,0001.14%
AdvisorShares Investments LLC 79,821$1,286,0000.80%
ETF MANAGERS GROUP, LLC 750,680$12,093,0000.42%
FARALLON CAPITAL MANAGEMENT LLC 2,300,000$37,053,0000.25%
View complete list of CARA THERAPEUTICS INC shareholders